IGC Pharma
6 hedge funds and large institutions have $363K invested in IGC Pharma in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VKH
1
Virtu KCG Holdings
New York
|
$33K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$15K |
| 3 |
U
3
UBS
Zurich,
Switzerland
|
$1K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Wells Fargo
San Francisco,
California
| $305K | 293,442 | – | – |
|
|
VKH
2
Virtu KCG Holdings
New York
| $33K | 31,671 | +31,671 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $15K | 14,956 | +14,956 | New |
|
4
Creative Planning
Overland Park,
Kansas
| $9K | 9,035 | – | – |
|
|
U
5
UBS
Zurich,
Switzerland
| $1K | 1,011 | +464 | +85% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $0 | 14 | +7 | +100% |
|